Oracle Corporation (ORCL) 2024 10-K Earnings Analysis
Oracle Corporation2024 Earnings Analysis
78/100
Oracle's FY2024 10-K (fiscal year ended May 31, 2024) captured the inflection where Oracle Cloud Infrastructure (OCI) finally became a credible hyperscaler: revenue of $53.0B produced $10.5B net income at 19.8% margin, with $11.8B FCF. The 10-K's strategic framing — 'we are in the early stages of an expected 'material migration' of the on-premise customer base toward Oracle Cloud per the FY2024 10-K to the Oracle Cloud' — captures the thesis. Cloud + license revenue growth accelerated; Fusion ERP and NetSuite extended the SaaS footprint. The 120% ROE on $8.7B equity (against $141B assets, 44% goodwill from the Cerner deal) reflects aggressive buybacks over decades.
Filing analysis
Oracle Corporation 2024 10-K Analysis
This page reads Oracle Corporation's 2024 10-K annual report through the EarningsMoat framework: earnings quality, economic moat strength, capital allocation, and key risks. The current overall score is 78/100, or grade C.
ORCL Earnings Quality
The earnings-quality module scores 82/100, with Net Margin: 19.8%, CF/Net Income: 1.78x. The core question is whether reported profit is backed by operating cash flow and recurring business economics. See the earnings quality analysis guide.
ORCL Economic Moat Analysis
The moat-strength module scores 88/100, with Database Switching Cost: Near-immovable, ERP + NetSuite Franchise: Strong. The test is whether the advantage can protect returns after competitors react. Read the economic moat analysis guide.
ORCL Free Cash Flow vs Net Income
CF/Net Income: 1.78x is the fastest read on whether accounting earnings turn into cash. The capital-allocation module scores 76/100. For the diagnostic, start with cash flow vs net income.
ORCL Key Risks from the Annual Report
The risk module scores 66/100, with OCI Scaling vs AWS/Azure: Uphill, Cerner Integration: Execution. The goal is to separate ordinary disclosure from risks that can change margins, cash flow, leverage, or the moat itself.
Is ORCL a High Quality Earnings Stock?
Based on this 2024 filing, ORCL passes the first screen for high-quality earnings: the overall grade is C, and the earnings-quality score is 82/100. This is a research screen, not investment advice.
Read the report first
Understand Oracle Corporation first, then decide if it belongs on your watchlist
The ORCL score, explanation, management facts, and filing sources are all here. When you want to follow more companies, review new-filing changes, or keep notes for the next review, keep more names in your watchlist.
Read the report first
Understand the company first. Keep up with every filing as your list grows.
A single report helps you judge one company. As your watchlist grows, review score, cash flow, moat, and risk changes together instead of repeating the same work.
Keep more names together
When your list grows, keep ORCL with the rest of your names and review score, grade, and risk changes over time.
See how to track more namesAsk follow-up questions
Dig into cash conversion, moat evidence, capital allocation, and risk changes without rereading the full 10-K.
Ask a questionExport and revisit records
Save the ORCL report as research notes you can revisit before the next filing.
Save research notesCore Dimension Scores
Evaluating competitive strength across earnings quality, moat strength, and risk sustainability
Overall Score Trend
Earnings Quality
Net income of $10.5B on $53B revenue = 19.8% net margin — strong for enterprise software, reflecting the deep profit pools in database support + ERP renewals. OCI is still sub-scale vs AWS/Azure, compressing blended software margins as compute/storage carries lower gross margin than pure license revenue.
OCF of $18.7B against NI of $10.5B = 1.78x — strong conversion. Deferred revenue from multi-year enterprise contracts (database licenses, cloud commits) structurally boosts OCF above GAAP NI.
The 10-K explicitly frames Oracle as 'in the early stages' of migrating 'our existing Oracle customer base from on-premise applications and infrastructure products and services to the Oracle Cloud.' Cloud + license revenue is where growth compounds; support + legacy segments stable or declining.
Capital expenditure of $6.9B on $53B revenue = 13% capex intensity — much higher than traditional software. OCI buildout (data centers, NVIDIA GPU orders for AI workloads) is the driver. Near-term FCF is compressed while capacity matures; analogous to LLY's GLP-1 capex cycle but in software.
Earnings quality scores 82/100. Strong margin + 1.78x CF/NI + high-quality recurring revenue base (support renewals from massive installed database + ERP footprint) confirms real earnings power. The OCI capex intensity is the one soft spot — it compresses near-term FCF relative to traditional software peers — but is a deliberate bet on a platform moat that compounds for a decade if the migration thesis holds.
Moat Strength
Oracle Database is the system-of-record for a majority of Fortune 500 mission-critical applications. Switching cost is enormous — migration to PostgreSQL, DynamoDB, or Aurora requires rewriting stored procedures, re-validating tooling, and accepting downtime risk. The 10-K's expectation that 'substantially all of our customers will renew their license support contracts' reflects this.
The 10-K describes 'Oracle Fusion Cloud Enterprise Resource Planning (ERP) is a strategic suite of applications that is foundational to facilitating and extracting more business value out of the adoption of other Oracle SaaS offerings.' NetSuite serves mid-market; Fusion ERP serves enterprise. Combined SaaS growth is mid-teens+.
OCI has evolved from an also-ran to a credible AWS/Azure alternative for specific workloads (Oracle database on Oracle Cloud optimization, AI training with NVIDIA GPU capacity). 10-K describes Oracle marketing OCI and Oracle SaaS 'to a broader ecosystem of small and medium-sized businesses, non-IT lines of business purchasers, developers and partners.'
The $28B Cerner acquisition (2022) added healthcare IT + EMR franchise. Integration ongoing: Cerner's VA contract and hospital customer relationships are assets, but healthcare IT carries lower margins and higher implementation risk than Oracle's traditional base.
Moat strength scores 88/100. Per the FY2024 10-K product disclosures, the Oracle Database is embedded in long-tenured customer relationships; management commentary in earnings calls has referenced high database-license renewal rates over time. ERP + NetSuite extend the moat into application layer. OCI is the newer leg — not yet AWS/Azure-scale but real for Oracle-centric workloads. Per the 2022 Cerner acquisition press release and subsequent 10-K disclosures, Cerner is an acquisition-driven diversification into the electronic-health-record market whose long-term contribution depends on execution.
Capital Allocation
FCF of $11.8B from $18.7B OCF minus $6.9B CapEx. FCF margin of 22% is solid but compressed by OCI buildout; historical Oracle FCF margin was closer to 30% before the cloud investment cycle.
ROE of 120.3% (NI $10.5B / Equity $8.7B) — engineered by decades of buybacks shrinking equity. Underlying ROA is 7.4% on $141B assets — more modest. The gap reflects capital-structure engineering, not underlying business returns.
Goodwill of $62B = 44% of assets — primarily from the $28B Cerner acquisition plus decades of tuck-in M&A. This is the highest goodwill ratio among this batch's peer set. If Cerner underperforms purchase-accounting assumptions, multi-billion impairment is possible.
Oracle has raised dividends for 15+ consecutive years. Combined with buybacks (slowed during OCI capex peak), annual capital return typically $10-12B. FCF coverage is tight given the buildout; pace may moderate until OCI matures.
Capital allocation scores 76/100. The 44% goodwill concentration is the scorecard's biggest drag — Cerner's $28B purchase price is large enough that any execution shortfall triggers material writedowns. Buybacks have been disciplined but the engineered 120% ROE is noise. Per the FY2024 cash flow statement, FCF coverage of capital return is the near-term balancing act; OCI capex is expected to normalize over the medium term as management-disclosed Oracle Cloud build-out cadence evolves.
Key Risks
OCI is the #4-5 hyperscaler (behind AWS, Azure, Google Cloud) and is catching up in specific niches (Oracle-workload optimization, AI GPU capacity). The gap to AWS/Azure is large; Oracle's differentiation is the installed-base migration thesis, which is asymmetric but unproven at scale.
The $28B Cerner deal added healthcare IT complexity. Integration is multi-year and success depends on whether Oracle can modernize Cerner's architecture while retaining VA contract + hospital customer relationships. Goodwill impairment is the downside case.
PostgreSQL, MongoDB, and cloud-native offerings (Aurora, DynamoDB) capture share in new application development. Oracle's installed base is sticky but new workloads increasingly skip Oracle. The switching-cost moat works on what's installed; it doesn't guarantee new business.
ERP cloud market is intensely competitive — SAP (S/4HANA Cloud) and Workday are well-funded direct competitors. NetSuite's mid-market position is defensible but enterprise ERP wins require multi-year displacement campaigns against SAP incumbency.
Risk profile scores 66/100 (higher = safer). Per management commentary in FY2024 earnings-call disclosures, OCI growth cadence is the principal variable — sustained growth reinforces the hyperscaler thesis, while deceleration would re-frame the capex-intensity narrative. Cerner integration is the secondary bet. Database share erosion is slow-moving. Overall the business is durable but the valuation narrative depends on growth execution.
Management
Ask about this section
Ask one question here. Keep digging when the issue needs more work.
This analysis is for educational purposes only and does not constitute investment advice.